Analyzing tubular adenoma and colonic innominate groove characteristics using endocytoscopy
Differentiation of Tubular Adenoma IIIL Duct Opening and Colonic Innominate Groove Under EC Endoscopy
This study is trying to see if special imaging can help doctors tell the difference between tubular adenomas and colonic innominate grooves in patients during endoscopic exams.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 96 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Jilin University Academic / other |
| Locations | 1 site (Chang chun, Ji Lin) |
| Trial ID | NCT06076369 on ClinicalTrials.gov |
What this trial studies
This observational study aims to differentiate between tubular adenomas and colonic innominate grooves by analyzing the characteristics of the IIIL duct opening under endocytoscopy. It will involve a prospective cohort of 96 participants, with a 1:2 pairing of 32 tubular adenoma lesions to 64 colonic innominate groove lesions. The study will take place over a recruitment period of 4 months, focusing on improving diagnostic accuracy in identifying these lesions during endoscopic examinations.
Who should consider this trial
Good fit: Ideal candidates include individuals with colorectal polyps who are undergoing endoscopic examination at the participating hospital.
Not a fit: Patients with hereditary polyposis, inflammatory bowel disease, or severe intestinal inflammation may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy of endoscopic diagnoses for colorectal lesions, leading to better patient management.
How similar studies have performed: While there have been studies on endoscopic techniques, this specific approach focusing on the differentiation of these lesions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cases of colorectal polyps discovered in our hospital and undergoing EC endoscopic examination. Exclusion Criteria: * 1.Suffering from hereditary polyposis or inflammatory bowel disease, severe intestinal inflammation, or difficulty recognizing normal intestinal mucosa; 2. History of methylene blue allergy; 3. Patients who have participated or are currently participating in other clinical trials within the first 4 weeks of enrollment;
Where this trial is running
Chang chun, Ji Lin
- the First Hospital of Jilin University — Chang chun, Ji Lin, China (Recruiting)
Study contacts
- Study coordinator: Hong Xu, professor
- Email: 18844097668@163.com
- Phone: 18844097668
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.